SCHEMBL7196679

SCHEMBL7196679

CCCC(C)Oc1cc(OC(C)CCC)c(OC(C)CCC)c(C(=O)CCc2cc(CC)ccc2OC(C)CCC)c1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.44
PPARD Q03181 20/20 0.44
PPARA Q07869 17/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7193985 0.94 PPARG (0.43) PPARGPPARDPPARA
SCHEMBL7194097 0.92 PPARG (0.37) PPARGPPARDPPARA
SCHEMBL7187738 0.89 PPARG (0.48) PPARGPPARDPPARA
SCHEMBL7195026 0.87 PPARG (0.44) PPARGPPARDPPARA
SCHEMBL7199234 0.85 PPARG (0.36) PPARGPPARDPPARA
SCHEMBL7189553 0.85 PPARG (0.44) PPARGPPARDPPARA
SCHEMBL7198834 0.85 PPARG (0.46) PPARGPPARDPPARA
SCHEMBL7189684 0.85 PPARG (0.42) PPARGPPARDPPARA
SCHEMBL7190583 0.83 PPARG (0.47) PPARGPPARDPPARA
SCHEMBL7194007 0.83 PPARG (0.46) PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 PPARG 659/4885PPARD 405/4885PPARA 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.